Single Dose, Weight-Based, Dose-Escalation Study With Intravenous ETI-204 in Adult Volunteers
Clinical trial NCT01453907 · COMPLETED
Trial details
- NCT number
- NCT01453907
- Sponsor
- Elusys Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-01
- Primary completion
- 2012-06-01
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.